Allentown, an Allentown, NJ-based provider of life science solutions and portfolio company of Aterian Investment Partners, acquired ClorDiSys Solutions, a Branchburg, NJ-based provider of Chlorine Dioxide-based solutions for sterilizing and decontaminating vivariums, laboratory equipment and medical devices.
The amount of the deal was not disclosed.
With the acquisition, Allentown will expand its offerings in the pre-clinical research and broader life sciences sector. The deal provides essential decontamination and sterilization products and services to vivarium research facilities within Allentown’s core biomedical pre-clinical industries. ClorDiSys additionally introduces Allentown to the adjacent and attractive medical device sterilization market.
Led by Paul Lorcheim, Director and co-founder, ClorDiSys is a premier provider of mission-critical, Chlorine Dioxide-based decontamination, disinfection, and sterilization solutions for a variety of end markets including life sciences, healthcare, and medical devices. Unlike other sterilization processes, ClorDiSys’ proprietary method of chlorine dioxide gas generation produces a non-acidic gas that is gentle on materials and electronics, does not result in harmful residues, is non-carcinogenic, non-explosive, and is a United States Environmental Protection Agency (EPA) registered sterilant.
Led by Charles Simmons, Chief Executive Officer, Allentown is a provider of solutions dedicated exclusively to the life science industry. From its family-founded origins as a local vivarium manufacturer, the company today has evolved into a suite of equipment and service solutions for the pre-clinical biomedical research and broader life sciences sectors.
FinSMEs
09/01/2024